Dimerix CEO Explains Company's Different Drug Combo R&D Strategy
Executive Summary
Global director of content for Informa Pharma Intelligence, Mike Ward, talks to Kathy Harrison, CEO of Australian biotech Dimerix, about the company's unusual business model.